Serum Institute of India, owned by Poonawala group is setting up first biotech SEZ at Hadapsar, near Pune. The SEZ, being developed by Serum Biopharma Park will entail an investment of Rs.1,200 crore. 

The proposed project coming up in an area of 55 acres of land will be implemented in phases. The company has allocated 55 acres of land for Phase-I which will be further expanded to 250 acres. The company will invest at least Rs.500 crore in the first phase and will raise funds through internal accruals as well as borrowings.

The new zone will manufacture vaccines for pneumonia, rotovirus, and combination vaccines for the entire range of meningitis and influenza. Oncological products for the US and EU markets is also expected to be manufactured at the new facility.

The institute will set up six units in this SEZ and a few units is expected to commence production by July 2006. The entire project is scheduled for completion by 2010.

The SEZ will stimulate economic activities by offering larger employment opportunities, attract substantial investments for export production and render services abroad to earn more foreign exchange.

Also see:

Poonawalla Group plans Rs.500 crore SEZ

 

← All latest storiesBack to top →